Therapeutic Asset Ratings
748 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Muc-1 Peptide Vaccine
Acute Myeloid Leukemia
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(40)
Mva-Pcaq
Prostate Cancer
Barinthus Biotherapeutics
P1/2
CC
(40)
Necvax-Neo1
Neoplasm
NEC Bio B.V
P1/2
CC
(40)
tg01
Plasma Cell Myeloma
Oslo University Hospital
P1/2
CC
(40)
Tozinameran
Acute Myeloid Leukemia
Assistance Publique - Hôpitaux de Paris
P1/2
CC
(40)
ak154
Malignant Pancreatic Neoplasm
Akeso
P1
C
(39)
Bacillus Calmette-Guerin
Rectal Cancer
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair
P1
C
(39)
BACILLUS CALMETTE-GUERIN LIVE (ATTENUATED) ANTIGEN
Rectal Carcinoma
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair
P1
C
(39)
Cp-Il22Bp Mrna Intratumorally
Solid Tumor Cancer
West China Hospital
P1
C
(39)
cvd908ssb-txsvn
Plasma Cell Myeloma
Baylor College of Medicine
P1
C
(39)
Hepatitis B Virus Vaccine
Colorectal Adenocarcinoma
National Cancer Institute (NCI)
P1
C
(39)
Iti-5000 Tnbc Vaccine
Triple-Negative Breast Carcinoma
Immunomic Therapeutics, Inc.
P1
C
(39)
Mammaglobin-A Dna Vaccine
Breast Cancer
Washington University School of Medicine
P1
C
(39)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine
Diffuse Large B-Cell Lymphoma
City of Hope Medical Center
P1
C
(39)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
City of Hope Medical Center
P1
C
(39)
Neoantigen Dna Vaccine
Colorectal Cancer
Centre Georges Francois Leclerc
P1
C
(39)
Neovax
Kidney Cancer
Patrick Ott, MD, PhD
P1
C
(39)
Neovax
Metastatic Melanoma
Dana-Farber Cancer Institute
P1
C
(39)
Optimized Neoantigen Synthetic Long Peptide Vaccine
Gastroesophageal Adenocarcinoma
Washington University School of Medicine
P1
C
(39)
Optimized Neoantigen Synthetic Long Peptide Vaccine
Pancreatic Neoplasm
Washington University School of Medicine
P1
C
(39)
Polio Vaccine
Breast Carcinoma
National Cancer Institute (NCI)
P1
C
(39)
Ppsv23
Colorectal Adenocarcinoma
National Cancer Institute (NCI)
P1
C
(39)
Quadrivalent Inactivated Influenza Vaccine
Metastatic Melanoma
Carlo Contreras
P1
C
(39)
Recombinant Vesicular Stomatitis Virus-Expressing Human Interferon Beta And Sodium-Iodide Symporter
Myelodysplastic Syndrome
Mayo Clinic
P1
C
(39)
Recombinant Vesicular Stomatitis Virus-Expressing Human Interferon Beta And Sodium-Iodide Symporter
Peripheral T Cell Lymphoma
Mayo Clinic
P1
C
(39)
Showing 601 to 625 of 748 assets
Previous
Page 25 of 30
Next
